These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

408 related items for PubMed ID: 17390757

  • 1. Allergen immunotherapy: present and future.
    Finegold I.
    Allergy Asthma Proc; 2007; 28(1):44-9. PubMed ID: 17390757
    [Abstract] [Full Text] [Related]

  • 2. Multiallergen immunotherapy for allergic rhinitis and asthma.
    Nelson HS.
    J Allergy Clin Immunol; 2009 Apr; 123(4):763-9. PubMed ID: 19217653
    [Abstract] [Full Text] [Related]

  • 3. [Allergic march in children, from rhinitis to asthma: management, indication of immunotherapy].
    Scheinmann P, Pham Thi N, Karila C, de Blic J.
    Arch Pediatr; 2012 Mar; 19(3):330-4. PubMed ID: 22306361
    [Abstract] [Full Text] [Related]

  • 4. [The value and possibilities of immunotherapy in the treatment of allergic rhinitis].
    Pfaar O, Hörmann K, Klimek L.
    MMW Fortschr Med; 2006 Feb 02; 148(5):28-32. PubMed ID: 16518935
    [Abstract] [Full Text] [Related]

  • 5. Sublingual immunotherapy.
    Lin SY, Leatherman B.
    Otolaryngol Clin North Am; 2011 Jun 02; 44(3):753-64, x-xi. PubMed ID: 21621059
    [Abstract] [Full Text] [Related]

  • 6. [Subcutaneous allergen-specific immunotherapy in patients with asthma and allergic rhinitis. 21st century].
    Martín JP.
    Rev Alerg Mex; 2009 Jun 02; 56(2):27-9. PubMed ID: 19526950
    [No Abstract] [Full Text] [Related]

  • 7. Multiallergen-specific immunotherapy in polysensitized patients: where are we?
    Bahceciler NN, Galip N, Cobanoglu N.
    Immunotherapy; 2013 Feb 02; 5(2):183-90. PubMed ID: 23413909
    [Abstract] [Full Text] [Related]

  • 8. Sublingual immunotherapy is not always a safe alternative to subcutaneous immunotherapy.
    Cochard MM, Eigenmann PA.
    J Allergy Clin Immunol; 2009 Aug 02; 124(2):378-9. PubMed ID: 19541352
    [No Abstract] [Full Text] [Related]

  • 9. Allergen immunotherapy for respiratory allergic disease in Australia in 2016.
    Smith WB, Kette FE.
    Med J Aust; 2017 Feb 06; 206(2):60-61. PubMed ID: 28152347
    [No Abstract] [Full Text] [Related]

  • 10. [Apropos of sublingual specific immunotherapy].
    Sabbah A.
    Allerg Immunol (Paris); 1998 Apr 06; 30(4):97-8. PubMed ID: 9631689
    [No Abstract] [Full Text] [Related]

  • 11. Subcutaneous versus sublingual immunotherapy for allergic rhinitis and/or asthma.
    Bahceciler NN, Cobanoglu N.
    Immunotherapy; 2011 Jun 06; 3(6):747-56. PubMed ID: 21668312
    [Abstract] [Full Text] [Related]

  • 12. Subcutaneous versus sublingual immunotherapy.
    Lin CH, Alandijani S, Lockey RF.
    Expert Rev Clin Immunol; 2016 Aug 06; 12(8):801-3. PubMed ID: 27253418
    [No Abstract] [Full Text] [Related]

  • 13. [Allergen-specific immunotherapy].
    Hansen TK, Svendsen UG.
    Ugeskr Laeger; 2005 Feb 07; 167(6):666-71. PubMed ID: 15771384
    [No Abstract] [Full Text] [Related]

  • 14. Sublingual immunotherapy: an update on immunologic and functional effects.
    Ciprandi G, Fenoglio D, Cirillo I, Tosca MA, La Rosa M, Licari A, Marseglia A, Barberi S, Marseglia GL.
    Allergy Asthma Proc; 2007 Feb 07; 28(1):40-3. PubMed ID: 17390756
    [Abstract] [Full Text] [Related]

  • 15. Allergen-specific immunotherapy in allergic rhinitis and asthma. Mechanisms and proof of efficacy.
    Pipet A, Botturi K, Pinot D, Vervloet D, Magnan A.
    Respir Med; 2009 Jun 07; 103(6):800-12. PubMed ID: 19216064
    [Abstract] [Full Text] [Related]

  • 16. Future developments in sublingual immunotherapy.
    Didier A.
    Allergy; 2006 Jun 07; 61 Suppl 81():29-31. PubMed ID: 16792604
    [Abstract] [Full Text] [Related]

  • 17. [Allergen specific immunotherapy: new approaches].
    Tay F, Kündig TM, Senti G.
    Praxis (Bern 1994); 2010 Oct 20; 99(21):1279-84. PubMed ID: 20960398
    [Abstract] [Full Text] [Related]

  • 18. [Vaccination with allergens in children].
    Demoly P, Dhivert-Donnadieu H, Bousquet J.
    Allerg Immunol (Paris); 2000 Dec 20; 32(10):397-401. PubMed ID: 11209473
    [Abstract] [Full Text] [Related]

  • 19. [Allergen-specific immunotherapy (hyposensitization). Part 2. Oral, sublingual and nasal application].
    Fuchs T, Klimek L.
    HNO; 2000 Feb 20; 48(2):158-64. PubMed ID: 10663067
    [No Abstract] [Full Text] [Related]

  • 20. Allergic rhinitis. Outcomes of immunotherapy on symptom control.
    Cook PR.
    Otolaryngol Clin North Am; 1998 Feb 20; 31(1):129-40. PubMed ID: 9530682
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.